Femasys (FEMY) Stock Price

Femasys Price

NASDAQ·CLOSED
2.06
​
Market closed

Revenue at Femasys has contracted by 12.9% per year over the past 6 years to 402,194.14 USD. For Femasys, the net margin of -4,631.6% is down versus -649.6% a few years ago. The consensus 12-month price target for Femasys is 6.12 USD, about 196.7% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Femasys stock price

Access this data via the Eulerpool API

Femasys business model & stock analysis

Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company is headquartered in Suwanee, Georgia and currently employs 34 full-time employees. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The firm also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Frequently asked questions about Femasys

Analysts currently set an average price target of 5.27 USD for the Femasys stock (median: 6.12 USD), implying +155.5 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Femasys stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Femasys to generate revenue of 2.09 M USD and earnings per share of -76.89 USD.

Converted at the current exchange rate, the Femasys share trades at 1.84 EUR (2.06 USD).

The Femasys share (FEMY) is listed on 1 stock exchanges, including: NASDAQ (FEMY).

The expected revenue of Femasys is 2.09 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Femasys is -152.05 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Femasys is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Femasys stock.

The price-to-sales ratio (P/S) of Femasys is currently 1.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Femasys stock.

The Eulerpool Quality Score for Femasys is 2/10.

The ISIN of Femasys is US31447E1055. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Femasys is FEMY. The ticker symbol is used to trade Femasys shares on the stock exchange.

Fair ValueTerminal
1.84 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
11,829.24 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website femasys.com
Currency
USD
Initial public offering
Jun 18, 2021
ISIN
US31447E1055
Cusip
31447E105
Market capitalization
120.61 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.03
P/Ee 2027
-0.03
P/Ee 2028
-0.06
P/Ee 2029
-0.41
P/Ee 2030
0.91
P/Se
1.96
EV/EBIT
—
P/B Ratio
20.55
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-176.30 %
Last updated Oct 9, 2026, 10:26 PM

Femasys Peer Group

Femasys Ticker

NASDAQ · FEMY

Femasys FIGI

FEMY:US · BBG004M23R63FEMY:UA · BBG0112Z8DY2FEMY:UC · BBG0112Z8DZ1FEMY:UN · BBG0112Z8F13FEMY:UP · BBG0112Z8F31FEMY:UB · BBG0112Z8F59FEMY:UM · BBG0112Z8F77FEMY:UX · BBG0112Z8F95FEMY:UR · BBG0112Z8FB2FEMY:UD · BBG0112Z8FG7FEMY:UF · BBG0112Z8FK2FEMY:VY · BBG0112Z8FL1

All fundamentals and in-depth analysis of Femasys

Our stock analysis for Femasys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Femasys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.